Table 1.
Baseline characteristics
| Characteristic | All patients | hsCRP < 2 mg/l | hsCRP ≥ 2 mg/l |
|---|---|---|---|
| n | 856 | 491 | 365 |
| Female sex | 27% | 27% | 27% |
| Age (yrs) | 71.75 | 72.08 | 71.32 |
| hsCRP (mg/l) | 2.43 | 0.91 | 4.48 |
| Lipoprotein (a) (mg/dl) | 33.33 | 30.78 | 36.63 |
| LDL-cholesterol (mg/dl) | 100.44 | 95.89 | 106.30 |
| HbA1c (%) | 6.11 | 6.04 | 6.19 |
| proBNP (pg/ml) | 1456.05 | 899.18 | 2294.60 |
| Hypertension | 80% | 80% | 81% |
| Diabetes | 29% | 26% | 32% |
| Smoking | 40% | 35% | 48% |
| BMI (kg/m2) | 26,82 | 26,23 | 27,63 |
| Stable CHD with revascularization procedure | 39% | 38% | 40% |
| History of acute coronary syndrome | 34% | 34% | 34% |
| No statin | 24% | 20% | 30% |
| Statin low dose | 26% | 26% | 25% |
| Statin high dose | 50% | 54% | 45% |
| Ezetimibe | 20% | 24% | 14% |
| PSCK9-inhibitor | 1% | 1% | 1% |
Normally distributed continuous variables are expressed as means; categorical variables are expressed as percent counts
yrs years, BMI body mass index, CHD coronary heart disease